Drugs Used in Heart Failure Flashcards
Characteristics of HF
Progressive and often fatal
Left ventricular dysfunction, reduced CO, insufficient tissue perfusion, signs of fluid retetion
5 million americans
Heart is unable to pump sufficient blood to meet the metabolic need of tissues
- Volume overload
- Inadequate tissue perfusion
The two forms of heart failure
Left ventricular systolic dysfunctions
Diastolic heart failure, also known as heart failure with preserved LV ejection fraction
HF: Causes
Chronic hypertension MI CAD dysarrhythmias ageing of the myocardium
HF: Physiologic adaptations
Reduced CO Cardiac dilation Increased sympathetic tone Water retention and increased blood volume Natriuretic peptides
HF: Signs and Symptoms
Decreased exercise tolerance Fatigue Shortness of breath Tachycardia Pulmonary and peripheral edema Hepatomegaly Distension of jugular veins Progressive disorder
HF: Pathogenesis
Decreased contractility
Increased cardiac workload
- Increases in HR, preload, afterload
HF: Compensatory mechanisms
RAA stimulation
ADH release, ANF release
Sympathetic stimulation
Cardiac dilation and hypertrophy
Remodeling
Changes in cardiomyocytes, extracellular matrix, changes in heart size, shape and function
Drugs Used to Treat HF
Thiazide Diuretics
Loop (high-ceiling) diuretic
Potassium- sparing diuretic
Drugs that inhibit RAAS
ACE inhibitors
Angiotensin II receptor blockers
Aldosterone antagonists
Direct renin inhibitors
ACE inhibitors: Hemodynamic benefits
Arteriolar dilation
Venous adilation
Suppression of aldosterone release
ACE Inhibitor: Impact on cardiac remodeling
Favorable impact
ACE Inhibitors: Adverse effects
Hypotension Hyperkalemia Intractable cough Angioedema Renal failure if patient has bilateral renal artery stenosis Can cause fetal injury
Angiotensin II receptor blockers
ARBs improve LV ejection fraction, reduce HF symptoms Increase exercise tolerance Decrease hospitalization Enhance quality of life Reduce mortality
Aldosterone antagonists: drugs
Spironolactone
Eplerenone
Aldosterone antagonists: Recommendations
Adding an aldosterone antagonist to standard HF therapy in patients with moderately severe or severe symptoms
Direct Renin Inhibitors
Benefits in HF about equal to ACE/ARBs
Aliskiren
What is the most common cause of secondary hyperaldosteronism?
Congestive heart failure